Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1862200 (
RHE
)
1,093
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A series of divalent first row triflate complexes supported by the ligand tris(2-pyridylmethyl)amine (
TPA
) have been investigated as oxygen reduction catalysts for fuel cell applications. [(
TPA
)M(2+)](n+) (M = Mn, Fe, Co, Ni, and Cu) derivatives were synthesized and characterized by X-ray crystallography, cyclic voltammetry, NMR spectroscopy, magnetic susceptibility, IR spectroscopy, and conductance measurements. The stoichiometric and electrochemical O(2) reactivities of the series were examined. Rotating-ring disk electrode (RRDE) voltammetry was used to examine the catalytic activity of the complexes on a carbon support in acidic media, emulating fuel cell performance. The iron complex displayed a selectivity of 89% for four-electron conversion and demonstrated the fastest reaction kinetics, as determined by a kinetic current of 7.6 mA. Additionally, the Mn, Co, and Cu complexes all showed selective four-electron oxygen reduction (<28% H(2)O(2)) at onset potentials (~0.44 V vs
RHE
) comparable to state of the art molecular catalysts, while being straightforward to access synthetically and derived from nonprecious metals.
...
PMID:Nonprecious metal catalysts for fuel cell applications: electrochemical dioxygen activation by a series of first row transition metal tris(2-pyridylmethyl)amine complexes. 2245 67
A series of copper complexes based on the tris(2-pyridylmethyl)amine (
TPA
) ligand are examined for their oxygen reduction reaction (ORR) activity. Increasing the potential of the Cu(I/II) couple from 0.23 V vs
RHE
for [Cu(
TPA
)(L)](2+) to 0.52 V for [Cu(TEPA)(L)](2+) (tris(2-pyridylethyl)amine) at pH 7 or adding a hydrogen-bonding secondary coordination sphere does not increase the onset potential from 0.69 V vs
RHE
for the ORR. The underlying mechanism for the ORR is determined to be first-order in O(2) and second-order in Cu. The rate-determining step is found to not be Cu(II) to Cu(I) reduction, as seen in other systems. The rate-determining step is also not the protonation of an intermediate, but may be the reduction of a hydroperoxo intermediate. Pyrolysis of the Cu complex of
TPA
affords an inactive material; activity is recovered through addition of intact
TPA
to the electrode surface.
...
PMID:Ligand effects on the overpotential for dioxygen reduction by tris(2-pyridylmethyl)amine derivatives. 2324 37